Last 12 months
Inside the activity.
25 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 13 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Mar 9, 2021 17:52 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
PurchaseCommon Stock | 750 | $13.81 | $10,357.50 |
DisclosureSEC source: 0001104659-21-033904 · tm219207d1_4seq1.xml · nonDerivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,490 Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:45 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 39,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031753 · tm218678d5_form4.xml · derivative · entry 2 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,542 Underlying: Common Stock · 39,680 shares Expires not disclosed F3 · security: The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of March 1, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:45 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 34,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031753 · tm218678d5_form4.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,862 Underlying: Common Stock · 34,759 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:44 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 28,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031749 · tm218678d2_form4.xml · derivative · entry 2 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,166 Underlying: Common Stock · 28,660 shares Expires not disclosed F3 · security: The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of March 1, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:44 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 27,434 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031749 · tm218678d2_form4.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,506 Underlying: Common Stock · 27,434 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:45 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 24,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031751 · tm218678d4_form4.xml · derivative · entry 2 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,755 Underlying: Common Stock · 24,248 shares Expires not disclosed F3 · security: The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of March 1, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:45 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 20,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031751 · tm218678d4_form4.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,507 Underlying: Common Stock · 20,402 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:44 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 18,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031750 · tm218678d3_form4.xml · derivative · entry 2 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,541 Underlying: Common Stock · 18,520 shares Expires not disclosed F3 · security: The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of March 1, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:44 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 20,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031750 · tm218678d3_form4.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,021 Underlying: Common Stock · 20,402 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:43 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 36,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031748 · tm218678d1_form4.xml · derivative · entry 2 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,373 Underlying: Common Stock · 36,740 shares Expires not disclosed F3 · security: The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of March 1, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 02:43 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 26,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-031748 · tm218678d1_form4.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,633 Underlying: Common Stock · 26,940 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 21:17 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit · Derivative | 3,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-102291 · tm2030203-3_4.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,246 Underlying: Common Stock · 3,116 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on September 2, 2021, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 17:19 UTC |
MOORE ROSCOE M JRDirector
|
GrantLTIP Unit · Derivative | 3,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-102293 · tm2030203-5_4.xml · derivative · entry 1 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,301 Underlying: Common Stock · 3,116 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on September 2, 2021, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 21:20 UTC |
Wittman LoriDirector
|
GrantLTIP Unit · Derivative | 3,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-102294 · tm2030203-6_4.xml · derivative · entry 1 Wittman Lori · CIK 0001615562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,301 Underlying: Common Stock · 3,116 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on September 2, 2021, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 21:18 UTC |
Marston RonaldDirector
|
GrantLTIP Unit · Derivative | 3,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-102292 · tm2030203-4_4.xml · derivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,246 Underlying: Common Stock · 3,116 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on September 2, 2021, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 21:14 UTC |
Crowley PaulaDirector
|
GrantLTIP Unit · Derivative | 3,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-102287 · tm2030203-2_4.xml · derivative · entry 1 Crowley Paula · CIK 0001743595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,301 Underlying: Common Stock · 3,116 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on September 2, 2021, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 21:12 UTC |
Cole HenryDirector
|
GrantLTIP Unit · Derivative | 3,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-102284 · tm2030203-1_4.xml · derivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,246 Underlying: Common Stock · 3,116 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on September 2, 2021, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| August 28, 2020 Filed Aug 28, 2020 20:24 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 21,242 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-100196 · tm2029817-1_4.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,072 Underlying: Common Stock · 21,242 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Compensation Committee of its Board of Directors determined that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of August 23, 2020 and 50% of the LTIP Units will vest on August 23, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 6, 2017, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting, subject to certain conditions, for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting, subject to certain conditions, for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting, subject to certain conditions, for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| August 12, 2020 Filed Aug 12, 2020 20:56 UTC |
Marston RonaldDirector
|
PurchaseCommon Stock | 2,000 | $13.30 | $26,600.00 |
DisclosureSEC source: 0001104659-20-093959 · tm2027437d1_4.xml · nonDerivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,830 Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 16:05 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
PurchaseCommon Stock | 10,000 | $13.39 | $133,900.00 |
DisclosureSEC source: 0001104659-20-092715 · tm2027145d1_form4.xml · nonDerivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,740 Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 16:07 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit · Derivative | 191,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-082726 · tm2024539d1_form4.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,103 Underlying: Common Stock · 191,205 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) on July 9, 2020. The LTIP Units vest in equal one-fourth installments on the first four anniversaries of the grant date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:07 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit · Derivative | 71,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-082728 · tm2024539d2_form4.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,830 Underlying: Common Stock · 71,702 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) on July 9, 2020. The LTIP Units vest in equal one-fourth installments on the first four anniversaries of the grant date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:08 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit · Derivative | 33,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-082731 · tm2024539d5_form4.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,105 Underlying: Common Stock · 33,461 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) on July 9, 2020. The LTIP Units vest in equal one-fourth installments on the first four anniversaries of the grant date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:07 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit · Derivative | 71,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-082729 · tm2024539d3_form4.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,693 Underlying: Common Stock · 71,702 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) on July 9, 2020. The LTIP Units vest in equal one-fourth installments on the first four anniversaries of the grant date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. Read SEC document |
| July 09, 2020 Filed Jul 10, 2020 20:08 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit · Derivative | 33,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-082730 · tm2024539d4_form4.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,619 Underlying: Common Stock · 33,461 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer, that were granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan (as amended from time to time) on July 9, 2020. The LTIP Units vest in equal one-fourth installments on the first four anniversaries of the grant date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock of the Issuer on a one-for-one basis. The LTIP Units have no expiration date. Read SEC document |
| May 12, 2020 Filed May 13, 2020 20:32 UTC |
Barber Jamie AllenSecretary and General Counsel
|
GrantLTIP Unit (Right to Buy) · Derivative | 14,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-060893 · tm2019615-1_4.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · Secretary and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,644 Underlying: Common Stock · 14,266 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Compensation Committee of its Board of Directors determined that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of May 8, 2020 and 50% of the LTIP Units will vest on May 8, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 6, 2017, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 12, 2020 Filed Mar 13, 2020 20:10 UTC |
Cole HenryDirector
|
PurchaseCommon Stock | 1,840 | $10.86 | $19,978.90 |
DisclosureSEC source: 0001104659-20-033121 · tm2012607d1_4.xml · nonDerivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,445 Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:28 UTC |
Webb AllenSVP
|
GrantLTIP Unit (Right to Buy) · Derivative | 20,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029824 · tm2011902-6_form4.xml · derivative · entry 3 Webb Allen · CIK 0001676513 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,582 Underlying: Common Stock · 20,780 shares Expires not disclosed F4 · security: The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of February 28, 2020 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 6, 2017, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:28 UTC |
Webb AllenSVP
|
GrantLTIP Unit (Right to Buy) · Derivative | 3,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029824 · tm2011902-6_form4.xml · derivative · entry 2 Webb Allen · CIK 0001676513 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,802 Underlying: Common Stock · 3,626 shares Expires not disclosed F3 · security: LTIP Units vest in equal one-third installments on March 3 of 2021, 2022 and 2023. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 5, 2020, and pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:28 UTC |
Webb AllenSVP
|
GrantLTIP Unit (Right to Buy) · Derivative | 10,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029824 · tm2011902-6_form4.xml · derivative · entry 1 Webb Allen · CIK 0001676513 · SVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,176 Underlying: Common Stock · 10,924 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2019 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit annual award vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 7, 2019, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:28 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 51,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029820 · tm2011902-2_form4.xml · derivative · entry 3 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,898 Underlying: Common Stock · 51,950 shares Expires not disclosed F4 · security: The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of February 28, 2020 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 6, 2017, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:28 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 6,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029820 · tm2011902-2_form4.xml · derivative · entry 2 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,948 Underlying: Common Stock · 6,415 shares Expires not disclosed F3 · security: LTIP Units vest in equal one-third installments on March 3 of 2021, 2022 and 2023. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 5, 2020, and pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:28 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 20,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029820 · tm2011902-2_form4.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,533 Underlying: Common Stock · 20,199 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2019 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit annual award vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 7, 2019, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029822 · tm2011902-4_form4.xml · derivative · entry 2 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,128 Underlying: Common Stock · 5,020 shares Expires not disclosed F3 · security: LTIP Units vest in equal one-third installments on March 3 of 2021, 2022 and 2023. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 5, 2020, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 16,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029822 · tm2011902-4_form4.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,108 Underlying: Common Stock · 16,832 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2019 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit annual award vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 7, 2019, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 20,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029821 · tm2011902-3_form4.xml · derivative · entry 3 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,158 Underlying: Common Stock · 20,780 shares Expires not disclosed F4 · security: The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of February 28, 2020 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.4 to the Issuer's Current Report on Form 8-K filed on March 6, 2017, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 3,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029821 · tm2011902-3_form4.xml · derivative · entry 2 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,378 Underlying: Common Stock · 3,905 shares Expires not disclosed F3 · security: LTIP Units vest in equal one-third installments on March 3 of 2021, 2022 and 2023. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 5, 2020, and pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 12,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029821 · tm2011902-3_form4.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,473 Underlying: Common Stock · 12,344 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2019 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit annual award vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 7, 2019, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 25,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029823 · tm2011902-5_form4.xml · derivative · entry 3 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,991 Underlying: Common Stock · 25,974 shares Expires not disclosed F4 · security: The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of February 28, 2020 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit performance-based vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 6, 2017, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,857 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029823 · tm2011902-5_form4.xml · derivative · entry 2 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,017 Underlying: Common Stock · 5,857 shares Expires not disclosed F3 · security: LTIP Units vest in equal one-third installments on March 3 of 2021, 2022 and 2023. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 5, 2020, and pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 16,832 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029823 · tm2011902-5_form4.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,160 Underlying: Common Stock · 16,832 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2019 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit annual award vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 7, 2019, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Barber Jamie AllenSecretary and General Counsel
|
GrantLTIP Unit (Right to Buy) · Derivative | 3,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029819 · tm2011902-1_form4.xml · derivative · entry 2 Barber Jamie Allen · CIK 0001705686 · Secretary and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,378 Underlying: Common Stock · 3,905 shares Expires not disclosed F3 · security: LTIP Units vest in equal one-third installments on March 3 of 2021, 2022 and 2023. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 5, 2020, and pursuant to the Issuer's 2016 Equity Incentive Plan and have no expiration date. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:28 UTC |
Barber Jamie AllenSecretary and General Counsel
|
GrantLTIP Unit (Right to Buy) · Derivative | 13,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-029819 · tm2011902-1_form4.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · Secretary and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,473 Underlying: Common Stock · 13,466 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 3, 2020 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of December 31, 2019 and 50% of the LTIP Units will vest on March 3, 2021, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to an LTIP Unit annual award vesting agreement, the form of which was filed as Exhibit 99.2 to the Issuer's Current Report on Form 8-K filed on March 7, 2019, and pursuant to the Issuer's 2016 Equity Incentive Plan. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| August 27, 2019 Filed Aug 29, 2019 12:03 UTC |
Cole HenryDirector
|
PurchaseCommon Stock | 1,485 | $10.80 | $16,038.00 |
DisclosureSEC source: 0001144204-19-042181 · tv528538_form4.xml · nonDerivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,605 Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 23:43 UTC |
Marston RonaldDirector
|
PurchaseCommon Stock | 200 | $10.69 | $2,138.00 |
DisclosureSEC source: 0001144204-19-041891 · tv528458_4.xml · nonDerivative · entry 3 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,830 Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 23:43 UTC |
Marston RonaldDirector
|
PurchaseCommon Stock | 1,500 | $10.72 | $16,080.00 |
DisclosureSEC source: 0001144204-19-041891 · tv528458_4.xml · nonDerivative · entry 2 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,630 Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 23:43 UTC |
Marston RonaldDirector
|
PurchaseCommon Stock | 1,300 | $10.68 | $13,884.00 |
DisclosureSEC source: 0001144204-19-041891 · tv528458_4.xml · nonDerivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,130 Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 19:33 UTC |
ZH USA, LLC10% owner
|
OtherCommon Stock | 3,715,611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001669358-19-000001 · primary_doc.xml · nonDerivative · entry 1 ZH USA, LLC · CIK 0001669358 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: On June 20, 2019, ZH USA, LLC, assigned 3,715,611 of the Issuer's common shares (which represented all of the Reporting Persons's interest in the Issuer's common shares) to its parent company, ZH International Holdings, Ltd. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 19:23 UTC |
ZH International Holdings, Ltd.10% owner
|
OtherCommon Stock | 3,715,611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001268576-19-000001 · primary_doc.xml · nonDerivative · entry 1 ZH International Holdings, Ltd. · CIK 0001268576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,715,611 F1 · price: On June 20, 2019, ZH International Holdings Ltd. received an assignment of 3,715,611 common shares of the Issuer from its wholly owned subsidiary, ZH USA, LLC. Read SEC document |
| May 29, 2019 Filed May 31, 2019 20:19 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit · Derivative | 3,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-029242 · tv522729_form4.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,130 Underlying: Common Stock · 3,705 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on May 29, 2020, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.